Lung Cancer (NSCLC)
Conditions
Brief summary
The goal of this retrospective, single-arm is to evaluate the safety and performance of the easyEndo™ Powered Single Use Powered Endoscopic Staplers and Cartridges in thoracic surgery. The main question it aims to answer is the safety and performance of the staplers
Interventions
DEVICEeasyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges
Using easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges transection, resection, and/or creation of anastomoses in thoracic surgery
Sponsors
Ezisurg Medical Co. Ltd.
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients who underwent thoracic surgery (including lobectomy, segmentectomy, wedge resection, etc.) using easyEndo™ Powered Single-Use Powered Endoscopic Staplers and Cartridges at our hospital. * Surgery date was on or after January 1, 2024. * Patients with complete medical records (including demographic data, surgical details, perioperative management, and follow-up information). * Patients who completed a 1-year postoperative follow-up, with available and valid follow-up data
Exclusion criteria
* Patients who used other brands or types of endoscopic staplers instead of easyEndo™ Powered Single-Use Powered Endoscopic Staplers and Cartridges during surgery. * Surgery date was before January 1, 2024. * Patients with incomplete medical records or missing key information (e.g., unclear surgical procedures, unrecorded stapler use details, lost to follow-up before 1 year). * Patients with severe underlying diseases that may affect postoperative outcomes or follow-up, such as end-stage heart, liver, or kidney disease, severe coagulation disorders, or uncontrolled malignant tumors (other than the primary disease requiring thoracic surgery). * Patients with allergies to the materials of easyEndo™ staplers or cartridges, or who experienced adverse reactions related to stapler material allergies intraoperatively or postoperatively.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| stapling success rate | Perioperative/Periprocedural | no leakage intra-operation and post-operation |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative blood loss volume | Perioperative/Periprocedural |
| Blood transfusion requirement | Perioperative/Periprocedural |
| Conversion to open thoracotomy | Perioperative/Periprocedural |
| Length of hospital stay | Perioperative/Periprocedural |
| Postoperative drainage duration | Perioperative/Periprocedural |
| total drainage volume | Perioperative/Periprocedural |
| Reoperation requirement | Perioperative/Periprocedural |
| The incidence of complications | 1 year |
Countries
China
Outcome results
None listed